Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Industry, Agencies Are Making COVID-19 Partnerships Easy

Apr 07 2020

• By Mandy Jackson

3D Coronavirus cells

Related Content

Coronavirus Notebook: US FDA's Paper Push, Industry Execs/US Officials Emphasize Their Collaboration

Apr 06 2020

Rapid Biopharma Response To COVID-19 Enabled By Decades Of R&D Investment, Firms Say

Apr 03 2020

J&J Ramps Up Manufacturing Capacity To Produce 1 Billion Doses Of Candidate COVID-19 Vaccine

Mar 30 2020

CEPI Expands COVID-19 Vaccine Portfolio, But Pleads For Big Funding Boost

Mar 13 2020

Coronavirus Sponsors Should Get Responses To Regulatory Requests Within One Day, US FDA Says

Apr 01 2020

Moderna Marches First Coronavirus Vaccine To US Test

Feb 25 2020

Experts Say COVID-19 Battle Needs More Funding, Cooperation

Mar 24 2020

Coronavirus: Gilead Readies For Remdesivir Ramp Up, Questions On Profit Motive

Mar 03 2020

Two Companies, Two BARDA Contracts, Two Approaches To Coronavirus

Feb 18 2020

Coronavirus Efforts Could Benefit From Little-Used Medical Countermeasures Incentives

Jan 30 2020

Related Companies

Johnson & Johnson

Sanofi

Inovio Pharmaceuticals, Inc.

Additional Topics

Coronavirus COVID-19 Deals Companies Strategy Research & Development Commercial Infectious Diseases BioPharmaceutical

More from COVID-19

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window